Genetic variation of interleukin-1 receptor type 1 is associated with severity of COVID-19 disease
Renxi Wang
Topics & Concepts
Cytokine stormInterleukin 1 receptor antagonistTocilizumabImmunologyGenetic variationAnakinraInterleukin 1 receptor, type IIInterleukin 10CytokineInterleukinInterleukin 6Coronavirus disease 2019 (COVID-19)DiseaseReceptorCoronavirusReceptor antagonistBiologyMedicineInternal medicineGeneticsGeneAntagonistInfectious disease (medical specialty)Interleukin 5Inflammasome and immune disordersCOVID-19 Clinical Research Studiesinterferon and immune responses